Chemours (CC) Change in Accured Expenses (2014 - 2026)

Chemours has reported Change in Accured Expenses for 13 years, with the latest figure at $205.0 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 173.33% year-over-year to $205.0 million in Q2 2026; TTM through Jun 2026 was $144.0 million, a 44.0% increase from a year earlier, with the FY2025 full-year figure at -$3.0 million, up 99.55% from the prior year.
• Change in Accured Expenses was $205.0 million for Q2 2026 at Chemours, up from $12.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $602.0 million in Q2 2023, with the low at -$644.0 million in Q2 2024.
• Average Change in Accured Expenses over 5 years is $8.3 million, with a median of $3.5 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses slumped 206.98% in 2024, then soared 340.0% in 2026.
• Over 5 years, Change in Accured Expenses stood at -$319.0 million in 2022, then jumped by 94.36% to -$18.0 million in 2023, then sank by 100.0% to -$36.0 million in 2024, then plunged by 163.89% to -$95.0 million in 2025, then soared by 315.79% to $205.0 million in 2026.
• The last three Change in Accured Expenses figures came in at $205.0 million (Q2 2026), $12.0 million (Q1 2026), and -$95.0 million (Q4 2025), per Business Quant data.